CRP and neoplasm: Increased levels of inflammatory markers such as neutrophils, CRP, CRP/Alb, and composite indices like NLR, PLR, SIRI, and SII have been associated with more aggressive tumor behavior, immunosuppressive tumor microenvironment, and limited therapeutic efficacy [7,8,9,10,19].